Description

This trans-national call supports international collaborations within personalised medicine. The focus is on testing and demonstrating new data-driven solutions for information-driven treatment and management of chronic diseases, especially where patients have multimorbidity (two or more chronic diseases). Vinnova finances Swedish participation in the joint call executed under EP PerMed.

Funding Amount 

• For Swedish parties: Up to SEK 3 million for one Swedish party over up to three years.
• If two or more Swedish parties participate in the same consortium, Vinnova may fund up to SEK 5 million total for the Swedish side.

Submission Deadlines

• International opening: 1 October 2025.
• Swedish national application opens: 8 October 2025.
• Last date for joint consortium submission (Step 1) to EP PerMed: 20 January 2026 at 14:00 CET.
• Step 2 full-proposal deadline to EP PerMed: 27 April 2026.
• Last date for parallel Swedish application (Step 2) to Vinnova: 5 May 2026.
• Decision (Step 2) expected: 1 September 2026.
• Project latest start date: 29 January 2027.
• Project maximum completion date: 29 January 2030.

Submission Conditions

• The project must be a trans-national consortium comprising at least three project partners from at least three participating countries. At least one Swedish applicant must participate.
• The consortium must include at least one company and one clinical partner (such as a health-care provider) as part of the Swedish participation.
• Swedish applicant must submit a parallel national application to Vinnova in addition to the international joint submission.
• The costs must relate to the Swedish legal entity and be recorded in Sweden as per Vinnova’s eligibility rules.
• Eligible cost types include personnel costs, equipment, land/buildings (if not regular business premises), consulting/licensing, other direct costs, overhead (indirect) up to 30% of personnel costs (higher for universities/research organisations).
• State aid rules apply for Swedish economic actors.
• The international consortium must follow EP PerMed eligibility (minimum three partners from three countries; at most two funded partners per country in most cases).

Eligible Types of Businesses

• Swedish actors eligible: enterprises (companies), public sector organisations, academia (universities, colleges, research institutes), non-governmental organisations.
• If more than one Swedish organisation participates, one must coordinate the Swedish participation.
• International consortium must include private sector (industry/SME), clinical/health-care partner, academic/research, etc. Patient/citizen-representing organisations may also participate (under EP PerMed rules) in some cases.

Eligible Countries

• For the Swedish national part: Swedish legal entities are eligible. The international part requires partners from at least three different participating countries (including Sweden).
• Participating countries in the EP PerMed call include many European Member States/Associated Countries.